Form 8-K - Current report:
SEC Accession No. 0000950170-25-068621
Filing Date
2025-05-12
Accepted
2025-05-12 08:52:59
Documents
12
Period of Report
2025-05-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sclx-20250509.htm   iXBRL 8-K 49380
2 EX-10.1 sclx-ex10_1.htm EX-10.1 15070
  Complete submission text file 0000950170-25-068621.txt   233526

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sclx-20250509.xsd EX-101.SCH 60677
14 EXTRACTED XBRL INSTANCE DOCUMENT sclx-20250509_htm.xml XML 6479
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25932813
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)